Videos

In this custom video series, key opinion leaders compare VMAT2 inhibitors available for use to treat patients with tardive dyskinesia.

In this custom video series, Leslie L. Citrome, MD, MPH, and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, caution against the use of anticholinergic medications for Parkinson’s disease and comment on the use of alternative therapies for appropriate patients.

In this custom video series, experts provide insight into strategies that may be helpful to healthcare professionals who manage patients on antipsychotic therapy to best monitor for signs of tardive dyskinesia, with special considerations regarding telepsychiatry.

In this custom video series, Leslie L. Citrome, MD, MPH, and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, reference the Abnormal Involuntary Movement Scale (AIMS) rating scale, used to assess the severity of involuntary movements and help diagnose tardive dyskinesia.

In this custom video series, key opinion leaders discuss what to know about the use of antipsychotic therapy and screening for signs of tardive dyskinesia, and starting treatment with a VMAT2 inhibitor.

Patients with intellectual or developmental disabilities need psychiatrists to learn some special skills.

In this custom video series, experts share overall impressions of a female patient with bipolar 1 disorder who develops new onset movements suggesting tardive dyskinesia and the rationale for intervening with VMAT2 therapy.

In this custom video series, Leslie L. Citrome, MD, MPH, and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC, review the case of a male patient with schizophrenia who develops symptoms of tardive dyskinesia and comments on the appropriateness for intervening with VMAT2 inhibitor therapy.

Are you having the conversation about food with your patients?

How are events from last week tied together?

Is unresolved trauma the number one problem on planet earth? An economist with expertise in disaster-related distress makes the case.

According to the Dalai Lama, physical care is not enough to achieve wellness.

June 21 is International Yoga Day!

A growing body of scientific evidence suggests that mind-altering drugs, combined with psychotherapy, are effective treatments for some of the most stubborn psychiatric disorders.

You must take care of yourself before you can take care of others.

For patients looking to supercharge their memory, what foods are best?

Health outcomes are often determined by factors outside of the hospital and clinic. How can psychiatrists address mental health challenges before they become emergencies?

One doctor travels around the world, building his mask collection.

The FDA approval of aducanumab has given hope to millions of patients with Alzheimer disease—but will it live up to the hype?

Medical aid in dying is available for psychiatric patients in European countries and Canada. Will the United States be next?

This new medication is a huge leap forward for treating attention-deficit/hyperactivity disorder.

Being unable to experience pleasure and having difficulty imagining future enjoyment are different problems—and may require different treatments.

What are the clinical benefits of TMS? How can you talk to your patients about this option?

What effect will aducanumab have on Alzheimer disease treatment?

The way were were back then, the way we are now, and maybe how we will be...

The latest trial results for MDMA-assisted therapy are in—and they are eye-catching.

What treatment options are available when dealing with delirium?

"...now i forget what day it is and still feel i’m running out of time..."

Kids will find the screens. Health care providers should join them in order to supply the most helpful digital treatments.

Key neural mechanisms are responsible for emotion, memory consolidation, and lasting personal change.